For female-amplifiers, we observed dysregulation of immune-related pathways, including interleukin-18-mediated signaling in LIHC, type I interferon signaling in HNSC, and antigen presentation via MHC class II in BLCA (Supplementary Fig. 5a and Supplementary Table 13). The gene discussed is IL18; the disease is bladder transitional cell carcinoma.